NDA[removed]S-009 Approved Labeling Enclosure Page 1 ATTACHMENT

First Page		Document Content
Date: 2004-01-13 09:43:38 Tetracyclic antidepressants Antiemetics Medicine Mirtazapine Antidepressant Management of depression Selective serotonin reuptake inhibitor Methadone Benzodiazepine Chemistry Amines Neurochemistry		NDA[removed]S-009 Approved Labeling Enclosure Page 1 ATTACHMENT Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 62,00 KB Share Document on Facebook

	NEW DRUG: Vilazodone (Viibryd®) Dan Anderson Los Angeles County Department of Coroner, 1104 N. Mission Road, Los Angeles, CAVilazodone (Viibyrd®) is a new antidepressant approved DocID: 1u71J - View Document
	NutraHacker Depression Side Effects Report for Customer: 16b3a1d2-1cc8-4b35-972c-b83fceb0a109 Instructions: This report analyzes polymorphisms that have been found to indicate side effects correlated with antidepressant DocID: 1tkwO - View Document
	Do not take extra medicine to treat tadalafil super active attention deficit hyperactivity disorder . an antidepressant--citalopram, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline. Answers from Donald Hens DocID: 1sM49 - View Document
	International Journal of Risk & Safety in Medicine–81 DOIJRSIOS Press 73 DocID: 1roTK - View Document
	Medication Guide Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions DocID: 1rlMD - View Document